Please provide your email address to receive an email when new articles are posted on . Qdata Geographic Atrophy will improve understanding of practice patterns, decision-making and outcomes. The ...

Geographic atrophy is a leading cause of blindness. The new approval will help to fill an unmet need for patients. The first ever treatment for geographic atrophy (GA) was approved by the FDA.

IZERVAY (avacincaptad pegol intravitreal solution) is a prescription eye injection, used to treat geographic atrophy (GA), the advanced form of dry age-related macular degeneration (AMD). Eye ...

Take these precautions to protect your eye health and preserve your vision. “Geographic atrophy is the thinning or the loss of tissue. Like how muscles atrophy and get thinner and weaker, the same ...

Geographic atrophy (GA) is a chronic, progressive degeneration of the macula that can occur in some people with dry macular degeneration. GA is a late, or advanced, stage of the disease. The people ...

Risdiplam, an oral pre–messenger RNA splicing modifier, is an efficacious treatment for persons with symptomatic spinal muscular atrophy (SMA). The safety and efficacy of risdiplam in presymptomatic ...

Please provide your email address to receive an email when new articles are posted on . Lesion-level analysis on OCT can help identify risk for atrophy, according to a speaker at Angiogenesis, ...

Intravitreal complement inhibitor injections (IVCIs) for geographic atrophy appeared to be acceptable to most patients if they assumed the treatment had functional vision benefits, a cross-sectional ...

While age and genetics are major unchangeable risk factors for geographic atrophy (GA), adopting healthy habits can help manage the risk. Smoking is strongly linked to increased risk and faster ...

Randomized trials of two FDA-approved intravitreal complement inhibitor injections showed that they slowed the progression of geographic atrophy, but failed to demonstrate functional benefits at 24 ...